Andreas Halvorsen acquired 10.8 Million Biomarin Pharmaceutical - Registered Shares shares worth $584 Million. That's 1.72% of their equity portfolio (21st largest holding). The investor owns 5.54% of the outstanding Biomarin Pharmaceutical - Registered Shares stock. The first Biomarin Pharmaceutical - Registered Shares trade was made in Q1 2016. Since then Andreas Halvorsen bought shares 21 more times and sold shares on nine occasions. The investor's estimated purchase price is $911 Million, resulting in a loss of 36%.